Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age

被引：0
|
作者：
Matt D. Wasserman
Johnna Perdrizet
Lindsay Grant
Kyla Hayford
Shubhra Singh
Paranjoy Saharia
Emily K. Horn
Raymond A. Farkouh
机构：
[1] Pfizer Inc.,Patient and Health Impact
[2] Health Economics and Outcomes Research,undefined
[3] Pfizer Inc.,undefined
[4] Medical and Scientific Affairs,undefined
[5] IQVIA,undefined
[6] Real-World Solutions,undefined
[7] Global Health Economics and Outcomes Research,undefined
[8] Pfizer Inc.,undefined
来源：
Infectious Diseases and Therapy | 2021年 / 10卷
关键词：
Invasive pneumococcal disease; Pneumococcal conjugate vaccine; Burden of disease; Vaccine serotypes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2701 / 2720
页数：19
相关论文
共 50 条
  • [11] Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review
    Ngocho, James Samwel
    Magoma, Best
    Olomi, Gaudencia Alois
    Mahande, Michael Johnson
    Msuya, Sia Emmanueli
    de Jonge, Marien Isaak
    Mmbaga, Blandina Theophil
    PLOS ONE, 2019, 14 (02):
  • [12] Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?
    Lindstrand, Ann
    Kalyango, Joan
    Alfven, Tobias
    Darenberg, Jessica
    Kadobera, Daniel
    Bwanga, Freddie
    Peterson, Stefan
    Henriques-Normark, Birgitta
    Kallander, Karin
    PLOS ONE, 2016, 11 (11):
  • [13] ECONOMIC BURDEN OF PNEUMOCOCCAL INFECTIONS IN CHILDREN UNDER FIVE YEARS OLD
    Ceyhan, M.
    Ozsurekci, Y.
    Aykac, K.
    VALUE IN HEALTH, 2015, 18 (07) : A417 - A417
  • [14] Burden of pneumococcal disease due to serotypes covered by the 13valent and new higher-valent pneumococcal conjugate vaccines in the United States
    Huang, Liping
    Wasserman, Matt
    Grant, Lindsay
    Farkouh, Raymond
    Snow, Vincenza
    Arguedas, Adriano
    Chilson, Erica
    Sato, Reiko
    Perdrizet, Johnna
    VACCINE, 2022, 40 (33) : 4700 - 4708
  • [15] Economic burden of pneumococcal infections in children under 5years of age
    Ceyhan, Mehmet
    Ozsurekci, Yasemin
    Aykac, Kubra
    Hacibedel, Basak
    Ozbilgili, Egemen
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (01) : 106 - 110
  • [16] Impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in children under 5 years of age in the Czech Republic
    Kozakova, Jana
    Krizova, Pavla
    Maly, Marek
    PLOS ONE, 2021, 16 (02):
  • [17] Pneumococcal carriage among children under five in Accra, Ghana, five years after the introduction of pneumococcal conjugate vaccine
    Dayie, Nicholas T. K. D.
    Tettey, Elizabeth Y.
    Newman, Mercy J.
    Bannerman, Elizabeth
    Donkor, Eric S.
    Labi, Appiah-Korang
    Slotved, Hans-Christian
    BMC PEDIATRICS, 2019, 19 (01) : 316
  • [18] Pneumococcal carriage among children under five in Accra, Ghana, five years after the introduction of pneumococcal conjugate vaccine
    Nicholas T. K. D. Dayie
    Elizabeth Y. Tettey
    Mercy J. Newman
    Elizabeth Bannerman
    Eric S. Donkor
    Appiah-Korang Labi
    Hans-Christian Slotved
    BMC Pediatrics, 19
  • [19] Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countries
    Hu, Tianyan
    Weiss, Thomas
    Bencina, Goran
    Owusu-Edusei, Kwame
    Petigara, Tanaz
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1098 - 1107
  • [20] ECONOMIC BURDEN OF PNEUMOCOCCAL DISEASE AMONG US CHILDREN - A REVIEW OF COST-EFFECTIVENESS ANALYSES OF PNEUMOCOCCAL VACCINES
    Huang, M.
    Xie, J.
    Elbasha, E.
    Mohanty, S.
    Kelly, M.
    VALUE IN HEALTH, 2024, 27 (06) : S90 - S90
12345